How Does Malaysia Address the Registration of Imported Drugs?

Malaysia addresses the registration of imported drugs through the National Pharmaceutical Regulatory Agency (NPRA). The process involves evaluating the drug’s safety, efficacy, and quality. Applicants must submit comprehensive documentation, including clinical data and manufacturing details. Upon approval, the drug is registered and granted a registration number for legal distribution.

Leave a Reply

You must be logged in to post a comment.